Skip to main content

Animations

MJFF Publications

4061 - 4070 of 8684 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Atypical antipsychotic use and mortality risk in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: The plight of loneliness in Parkinson's disease: New opportunities
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.011
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Auto-annotating sleep stages based on polysomnographic data
    Journal Name: Patterns
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.patter.2021.100371
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.04.001
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.